Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa.

ABSTRACT: Anorexia nervosa (AN) is a complex psychiatric disorder with high morbidity and mortality rates. While many individuals make full recoveries, up to a third of patients develop a chronic, treatment-resistant form of the illness that leads to a premature death in 15-20% of those affected. There have been few advances in treatment, both in terms of psychological or pharmacologic treatment over the last 30 years. Food aversion is commonly cited by patients with AN as a barrier to normalizing eating and weight. Our group has a keen interest in examining factors that might allow this to be addressed, thus improving treatment outcomes through personalized dietary plans or nutritional supplementation related to underlying genetic status. We demonstrated that polyunsaturated fatty acids (PUFAs)-der

SUBMITTER: Shih PB 

PROVIDER: S-EPMC5792652 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature